HIGHLIGHTS
- who: Angela Mauro from the University of L`Aquila, Italy have published the research: Off-label use of canakinumab in pediatric rheumatology and rare diseases, in the Journal: (JOURNAL)
- what: The aim of this review is to describe the currently available literature for the off-label use of CAN in pediatric patients suffering from immune-mediated disorders. Use of canakinumab in specific diseases Search methods This narrative review was conducted in accordance with the IMRAD (Introduction, Methods, Results, and Discussion) approach . A combination of MeSH terms and keywords was employed to retrieve relevant articles serving . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.